These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis and Biological Evaluation of N(2) -Substituted 2,4-Diamino-6-cyclohexylmethoxy-5-nitrosopyrimidines and Related 5-Cyano-NNO-azoxy Derivatives as Cyclin-Dependent Kinase 2 (CDK2) Inhibitors. Cortese D; Chegaev K; Guglielmo S; Wang LZ; Golding BT; Cano C; Fruttero R ChemMedChem; 2016 Aug; 11(16):1705-8. PubMed ID: 27355194 [TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase inhibition by new C-2 alkynylated purine derivatives and molecular structure of a CDK2-inhibitor complex. Legraverend M; Tunnah P; Noble M; Ducrot P; Ludwig O; Grierson DS; Leost M; Meijer L; Endicott J J Med Chem; 2000 Apr; 43(7):1282-92. PubMed ID: 10753466 [TBL] [Abstract][Full Text] [Related]
6. Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives. Gibson AE; Arris CE; Bentley J; Boyle FT; Curtin NJ; Davies TG; Endicott JA; Golding BT; Grant S; Griffin RJ; Jewsbury P; Johnson LN; Mesguiche V; Newell DR; Noble ME; Tucker JA; Whitfield HJ J Med Chem; 2002 Aug; 45(16):3381-93. PubMed ID: 12139449 [TBL] [Abstract][Full Text] [Related]
8. Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. Mettey Y; Gompel M; Thomas V; Garnier M; Leost M; Ceballos-Picot I; Noble M; Endicott J; Vierfond JM; Meijer L J Med Chem; 2003 Jan; 46(2):222-36. PubMed ID: 12519061 [TBL] [Abstract][Full Text] [Related]